Wahed FTSE USA Shariah ETF vs Regeneron Pharmaceuticals Inc — how do they compare? Wahed FTSE USA Shariah ETF trades at $73, while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Wahed FTSE USA Shariah ETF pays none. Which is the better fit depends on your goals.
| HLAL | REGN | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $73.60 | $812.27 |
52-Week Low | $55.52 | $555.51 |
Market Cap | — | $82.06B |
Enterprise Value | — | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
HLAL is an ETF that invests in Shariah-compliant US companies. It follows a rigorous screening process to exclude businesses involved in non-compliant activities like interest-based finance, alcohol, and gambling.
Read more on HLAL →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →